Sen. Markwayne Mullin Buys Elevance Health, Inc. (NYSE:ELV) Shares

Senator Markwayne Mullin (R-Oklahoma) recently bought shares of Elevance Health, Inc. (NYSE:ELV). In a filing disclosed on January 16th, the Senator disclosed that they had bought between $15,001 and $50,000 in Elevance Health stock on December 29th.

Senator Markwayne Mullin also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Deere & Company (NYSE:DE) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of Hilton Worldwide (NYSE:HLT) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of RTX (NYSE:RTX) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of CocaCola (NYSE:KO) on 12/29/2025.
• Purchased $1,001 – $15,000 in shares of American Express (NYSE:AXP) on 12/29/2025.
• Purchased $100,001 – $250,000 in shares of Amazon.com (NASDAQ:AMZN) on 12/29/2025.
• Purchased $50,001 – $100,000 in shares of JPMorgan Chase & Co. (NYSE:JPM) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of The Goldman Sachs Group (NYSE:GS) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of Boston Scientific (NYSE:BSX) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of Home Depot (NYSE:HD) on 12/29/2025.

Elevance Health Stock Down 1.9%

ELV traded down $7.07 during trading on Friday, hitting $374.86. 1,074,663 shares of the company’s stock traded hands, compared to its average volume of 1,146,480. The stock has a market capitalization of $83.31 billion, a price-to-earnings ratio of 15.33, a PEG ratio of 1.93 and a beta of 0.51. The company’s 50 day simple moving average is $344.10 and its two-hundred day simple moving average is $328.03. Elevance Health, Inc. has a 12-month low of $273.71 and a 12-month high of $458.75. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 0.71.

Elevance Health (NYSE:ELV) last announced its quarterly earnings results on Tuesday, October 21st. The company reported $6.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.03 by $1.00. Elevance Health had a return on equity of 16.17% and a net margin of 2.84%.The firm had revenue of $50.09 billion for the quarter, compared to the consensus estimate of $49.26 billion. During the same period in the prior year, the company posted $8.37 earnings per share. The company’s quarterly revenue was up 12.0% on a year-over-year basis. Analysts predict that Elevance Health, Inc. will post 33.96 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on ELV. Weiss Ratings upgraded shares of Elevance Health from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, January 12th. The Goldman Sachs Group initiated coverage on Elevance Health in a report on Tuesday, October 14th. They set a “neutral” rating and a $343.00 price target on the stock. Wolfe Research set a $425.00 price objective on Elevance Health and gave the company an “outperform” rating in a research report on Thursday, January 8th. TD Cowen raised their target price on Elevance Health from $380.00 to $400.00 and gave the stock a “buy” rating in a research report on Wednesday, November 26th. Finally, Barclays upped their price target on shares of Elevance Health from $385.00 to $404.00 and gave the company an “overweight” rating in a research report on Monday, January 5th. Thirteen equities research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company. Based on data from MarketBeat, Elevance Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $400.85.

Hedge Funds Weigh In On Elevance Health

A number of hedge funds have recently modified their holdings of ELV. Aaron Wealth Advisors LLC increased its stake in Elevance Health by 66.5% in the 2nd quarter. Aaron Wealth Advisors LLC now owns 1,087 shares of the company’s stock worth $423,000 after buying an additional 434 shares in the last quarter. Goelzer Investment Management Inc. raised its stake in Elevance Health by 61.7% during the 2nd quarter. Goelzer Investment Management Inc. now owns 1,332 shares of the company’s stock valued at $518,000 after purchasing an additional 508 shares during the period. Chesley Taft & Associates LLC lifted its holdings in Elevance Health by 3.1% in the 2nd quarter. Chesley Taft & Associates LLC now owns 3,804 shares of the company’s stock worth $1,480,000 after purchasing an additional 115 shares in the last quarter. Pines Wealth Management LLC boosted its stake in Elevance Health by 29.5% in the 2nd quarter. Pines Wealth Management LLC now owns 694 shares of the company’s stock worth $270,000 after purchasing an additional 158 shares during the period. Finally, Dynamic Advisor Solutions LLC grew its holdings in Elevance Health by 11.3% during the 2nd quarter. Dynamic Advisor Solutions LLC now owns 8,034 shares of the company’s stock valued at $3,125,000 after buying an additional 817 shares in the last quarter. 89.24% of the stock is currently owned by institutional investors.

About Senator Mullin

Markwayne Mullin (Republican Party) is a member of the U.S. Senate from Oklahoma. He assumed office on January 11, 2023. His current term ends on January 3, 2027. Mullin (Republican Party) ran in a special election to the U.S. Senate to represent Oklahoma. He won in the special general election on November 8, 2022. Mullin is a member of the Cherokee Nation and one of four Native American members of the 116th Congress. At the age of 20, Mullin took over his father’s plumbing business. He is also a former professional mixed martial artist. Markwayne Mullin graduated from Stilwell High School. Mullin earned an associate degree in construction technology from Oklahoma State University Institute of Technology. His career experience includes owning and founding multiple businesses.

About Elevance Health

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.